Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy

Introduction Sleep and epilepsy have an established bidirectional relationship yet only one randomised controlled clinical trial has assessed the effectiveness of behavioural sleep interventions for children with epilepsy. The intervention was successful, but was delivered via face-to-face educational sessions with parents, which are costly and non-scalable to population level. The Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E trial addresses this problem by comparing clinical and cost-effectiveness in children with Rolandic epilepsy between standard care (SC) and SC augmented with a novel, tailored parent-led CASTLE Online Sleep Intervention (COSI) that incorporates evidence-based behavioural components. Methods and analyses CASTLE Sleep-E is a UK-based, multicentre, open-label, active concurrent control, randomised, parallel-group, pragmatic superiority trial. A total of 110 children with Rolandic epilepsy will be recruited in outpatient clinics and allocated 1:1 to SC or SC augmented with COSI (SC+COSI). Primary clinical outcome is parent-reported sleep problem score (Children’s Sleep Habits Questionnaire). Primary health economic outcome is the incremental cost-effectiveness ratio (National Health Service and Personal Social Services perspective, Child Health Utility 9D Instrument). Parents and children (≥7 years) can opt into qualitative interviews and activities to share their experiences and perceptions of trial participation and managing sleep with Rolandic epilepsy. Ethics and dissemination The CASTLE Sleep-E protocol was approved by the Health Research Authority East Midlands (HRA)–Nottingham 1 Research Ethics Committee (reference: 21/EM/0205). Trial results will be disseminated to scientific audiences, families, professional groups, managers, commissioners and policymakers. Pseudo-anonymised individual patient data will be made available after dissemination on reasonable request. Trial registration number ISRCTN13202325.

[1]  S. Pudney,et al.  Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data , 2022, Health economics.

[2]  H. Hiscock,et al.  A Qualitative Investigation Into What Parents Want From an Online Behavioural Sleep Intervention for Children With Epilepsy , 2021, Frontiers in Psychology.

[3]  H. Hiscock,et al.  Development and Evaluation of the CASTLE Trial Online Sleep Intervention for Parents of Children with Epilepsy , 2021, Frontiers in Psychology.

[4]  M. Brandon Westover,et al.  Computational Evidence for a Competitive Thalamocortical Model of Spikes and Spindle Activity in Rolandic Epilepsy , 2021, Frontiers in Computational Neuroscience.

[5]  E. Basch,et al.  SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials , 2021, BMJ Open.

[6]  P. Willeit,et al.  Sleep quality and daytime sleepiness in epilepsy: Systematic review and meta-analysis of 25 studies including 8,196 individuals. , 2021, Sleep medicine reviews.

[7]  S. Kyle,et al.  Reporting of adverse events in cognitive behavioural therapy for insomnia: A systematic examination of randomised controlled trials. , 2020, Sleep medicine reviews.

[8]  P. Carlbring,et al.  Testing an app-based intervention to improve insomnia in patients with epilepsy: A randomized controlled trial , 2020, Epilepsy & Behavior.

[9]  J. Arabloo,et al.  Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments , 2020, Pediatrics.

[10]  S. Lah,et al.  Behavioral Interventions for Sleep Disturbances in Children with Neurological and Neurodevelopmental Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials. , 2020, Sleep.

[11]  M. Kramer,et al.  The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS) , 2020, Epilepsy & Behavior.

[12]  J. Stephen,et al.  Temporal trends in incidence of Rolandic epilepsy, prevalence of comorbidities and prescribing trends: birth cohort study , 2020, Archives of Disease in Childhood.

[13]  S. Jeng,et al.  Behavioral-Educational Sleep Interventions for Pediatric Epilepsy: A Randomized Controlled Trial. , 2020, Sleep.

[14]  E. Spitznagel,et al.  Importance of Defining and Interpreting a Clinically Meaningful Difference in Clinical Research. , 2019, JAMA otolaryngology-- head & neck surgery.

[15]  D. Pal,et al.  Practical aspects of childhood epilepsy , 2019, BMJ.

[16]  G. Andersson,et al.  Comparing internet-delivered cognitive therapy and behavior therapy with telephone support for insomnia disorder: a randomized controlled trial , 2019, Sleep.

[17]  B. Carter,et al.  Core Health Outcomes in Childhood Epilepsy (CHOICE): Development of a core outcome set using systematic review methods and a Delphi survey consensus , 2019, Epilepsia.

[18]  Fares Alahdab,et al.  Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[19]  L. Prosser,et al.  Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature , 2019, PharmacoEconomics.

[20]  P. Gringras,et al.  Sleep and epilepsy: unfortunate bedfellows , 2018, Archives of Disease in Childhood.

[21]  Anna B. Smith,et al.  The Effects of Sleep on Emotional Target Detection Performance: A Novel iPad-Based Pediatric Game , 2018, Front. Psychol..

[22]  Per Winkel,et al.  When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts , 2017, BMC Medical Research Methodology.

[23]  P. Williamson,et al.  Core Health Outcomes In Childhood Epilepsy (CHOICE): protocol for the selection of a core outcome set , 2017, Trials.

[24]  Brendan Mulhern,et al.  Valuing health‐related quality of life: An EQ‐5D‐5L value set for England , 2017, Health economics.

[25]  D G Altman,et al.  GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research , 2017, British Medical Journal.

[26]  Angus G K McNair,et al.  The COMET Handbook: version 1.0 , 2017, Trials.

[27]  A. Sadeh,et al.  Validation of actigraphy with continuous video-electroencephalography in children with epilepsy. , 2014, Sleep medicine.

[28]  K. Chalkidou.  About the National Institute for Health and Care Excellence - NICE. , 2013, Acta medica portuguesa.

[29]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. , 2013, BMJ.

[30]  D. Rennie,et al.  SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.

[31]  David Moher,et al.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.

[32]  Katherine Stevens,et al.  Valuation of the Child Health Utility 9D Index , 2012, PharmacoEconomics.

[33]  A. Shoeb,et al.  Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents , 2012, Epilepsia.

[34]  G. Schulte-Körne,et al.  Depression in pediatric care: is the WHO-Five Well-Being Index a valid screening instrument for children and adolescents? , 2012, General hospital psychiatry.

[35]  B. van Hout,et al.  Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities , 2011, Health and quality of life outcomes.

[36]  C. Morin,et al.  The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. , 2011, Sleep.

[37]  D. Mohr,et al.  Usual and Unusual Care: Existing Practice Control Groups in Randomized Controlled Trials of Behavioral Interventions , 2011, Psychosomatic medicine.

[38]  Stavros Petrou,et al.  Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[39]  D. Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[40]  Michael Herdman,et al.  Development of the EQ-5D-Y: a child-friendly version of the EQ-5D , 2010, Quality of Life Research.

[41]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[42]  D. Schoenfeld,et al.  Usual care as the control group in clinical trials of nonpharmacologic interventions. , 2007, Proceedings of the American Thoracic Society.

[43]  D. Streiner,et al.  Health‐related Quality of Life in Children with Epilepsy: Development and Validation of Self‐report and Parent Proxy Measures , 2003, Epilepsia.

[44]  M. Sculpher,et al.  Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.

[45]  R. Goodman,et al.  Psychometric properties of the strengths and difficulties questionnaire. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  J. Owens,et al.  The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. , 2000, Sleep.

[47]  Mark W. Roosa,et al.  Examination of the Cross-cultural and Cross-language Equivalence of the Parenting Self-Agency Measure. , 1996 .

[48]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[49]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[50]  M. Egger,et al.  Pragmatic trials : defining questions , choosing comparators , allocating treatments 1 2 , 2017 .

[51]  Andrea Manca,et al.  Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials , 2005, Applied health economics and health policy.

[52]  L. Gooding.  Children's. , 2005, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[53]  E S Geller,et al.  Behavioral interventions. , 1988, Bulletin of the New York Academy of Medicine.